Krishgen (131)

KRIBIOLISA™ Cixutumumab ELISA

Reference: KBI1234

€0.00 (tax incl.)

The Cixutumumab ELISA kit is intended for the quantitative determination of Cixutumumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Clazakizumab ELISA

Reference: KBI1235

€0.00 (tax incl.)

The Clazakizumab ELISA kit is intended for the quantitative determination of Clazakizumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Clivatuzumab Tetraxetan ELISA

Reference: KBI1237

€0.00 (tax incl.)

The Clivatuzumab Tetraxetan ELISA kit is intended for the quantitative determination of Clivatuzumab Tetraxetan in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Cobolimab ELISA

Reference: KBI1239

€0.00 (tax incl.)

The Cobolimab ELISA kit is intended for the quantitative determination of Cobolimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Codrituzumab ELISA

Reference: KBI1240

€0.00 (tax incl.)

The Codrituzumab ELISA kit is intended for the quantitative determination of Codrituzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Cofetuzumab Pelidotin ELISA

Reference: KBI1242

€0.00 (tax incl.)

The Cofetuzumab Pelidotin ELISA kit is intended for the quantitative determination of Cofetuzumab Pelidotin in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Concizumab ELISA

Reference: KBI1245

€0.00 (tax incl.)

The Concizumab ELISA kit is intended for the quantitative determination of Concizumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Cosibelimab ELISA

Reference: KBI1247

€0.00 (tax incl.)

The Cosibelimab ELISA kit is intended for the quantitative determination of Cosibelimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Crenezumab ELISA

Reference: KBI1248

€0.00 (tax incl.)

The Crenezumab ELISA kit is intended for the quantitative determination of Crenezumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Crizanlizumab (ADAKVEO) ELISA

Reference: KBI1249

€0.00 (tax incl.)

The Crizanlizumab ELISA kit is intended for the quantitative determination of Crizanlizumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Crovalimab ELISA

Reference: KBI1251

€0.00 (tax incl.)

The Crovalimab ELISA kit is intended for the quantitative determination of Crovalimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Cusatuzumab ELISA

Reference: KBI1252

€0.00 (tax incl.)

The Cusatuzumab ELISA kit is intended for the quantitative determination of Cusatuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dacetuzumab ELISA

Reference: KBI1253

€0.00 (tax incl.)

The Dacetuzumab ELISA kit is intended for the quantitative determination of Dacetuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dalotuzumab ELISA

Reference: KBI1256

€0.00 (tax incl.)

The Dalotuzumab ELISA kit is intended for the quantitative determination of Dalotuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dapirolizumab Pegol ELISA

Reference: KBI1257

€0.00 (tax incl.)

The Dapirolizumab Pegol ELISA kit is intended for the quantitative determination of Dapirolizumab Pegol in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Denintuzumab Mafodotin ELISA

Reference: KBI1260

€0.00 (tax incl.)

The Denintuzumab Mafodotin ELISA kit is intended for the quantitative determination of Denintuzumab Mafodotin in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Depatuxizumab Mafodotin ELISA

Reference: KBI1262

€0.00 (tax incl.)

The Depatuxizumab Mafodotin ELISA kit is intended for the quantitative determination of Depatuxizumab Mafodotin in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dezamizumab ELISA

Reference: KBI1265

€0.00 (tax incl.)

The Dezamizumab ELISA kit is intended for the quantitative determination of Dezamizumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dilpacimab ELISA

Reference: KBI1266

€0.00 (tax incl.)

The Dilpacimab ELISA kit is intended for the quantitative determination of Dilpacimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Disitamab Vedotin ELISA

Reference: KBI1271

€0.00 (tax incl.)

The Disitamab Vedotin ELISA kit is intended for the quantitative determination of Disitamab Vedotin in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dostarlimab ELISA

Reference: KBI1275

€0.00 (tax incl.)

The Dostarlimab ELISA kit is intended for the quantitative determination of Dostarlimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Drozitumab ELISA

Reference: KBI1277

€0.00 (tax incl.)

The Drozitumab ELISA kit is intended for the quantitative determination of Drozitumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Duligotuzumab ELISA

Reference: KBI1278

€0.00 (tax incl.)

The Duligotuzumab ELISA kit is intended for the quantitative determination of Duligotuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Dupilumab (DUPIXENT) ELISA

Reference: KBI1279

€0.00 (tax incl.)

The Dupilumab ELISA kit is intended for the quantitative determination of Dupilumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Efalizumab (RAPTIVA) ELISA

Reference: KBI1286

€0.00 (tax incl.)

The Efalizumab ELISA kit is intended for the quantitative determination of Efalizumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Elezanumab ELISA

Reference: KBI1289

€0.00 (tax incl.)

The Elezanumab ELISA kit is intended for the quantitative determination of Elezanumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Elgemtumab ELISA

Reference: KBI1290

€0.00 (tax incl.)

The Elgemtumab ELISA kit is intended for the quantitative determination of Elgemtumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Elipovimab ELISA

Reference: KBI1291

€0.00 (tax incl.)

The Elipovimab ELISA kit is intended for the quantitative determination of Elipovimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Elotuzumab (EMPLICITI) ELISA

Reference: KBI1292

€0.00 (tax incl.)

The Elotuzumab ELISA kit is intended for the quantitative determination of Elotuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Emactuzumab ELISA

Reference: KBI1294

€0.00 (tax incl.)

The Emactuzumab ELISA kit is intended for the quantitative determination of Emactuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Emapalumab (GAMIFANT) ELISA

Reference: KBI1295

€0.00 (tax incl.)

The Emapalumab ELISA kit is intended for the quantitative determination of Emapalumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Emibetuzumab ELISA

Reference: KBI1296

€0.00 (tax incl.)

The Emibetuzumab ELISA kit is intended for the quantitative determination of Emibetuzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Emicizumab (HEMLIBRA) ELISA

Reference: KBI1297

€0.00 (tax incl.)

The Emicizumab ELISA kit is intended for the quantitative determination of Emicizumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Enapotamab (HUMAX-AXL-ADC) ELISA

Reference: KBI1298

€0.00 (tax incl.)

The Enapotamab ELISA kit is intended for the quantitative determination of Enapotamab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Enfortumab Vedotin (PADCEV) ELISA

Reference: KBI1302

€0.00 (tax incl.)

The Enfortumab Vedotin ELISA kit is intended for the quantitative determination of Enfortumab Vedotin in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Enoblituzumab ELISA

Reference: KBI1305

€0.00 (tax incl.)

The Enoblituzumab ELISA kit is intended for the quantitative determination of Enoblituzumab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Envafolimab ELISA

Reference: KBI1309

€0.00 (tax incl.)

The Envafolimab ELISA kit is intended for the quantitative determination of Envafolimab in serum, plasma and cell culture samples. RUO only.

KRIBIOLISA™ Epcoritamab (DUOBODY-CD3xCD20) ELISA

Reference: KBI1310

€0.00 (tax incl.)

Epcoritamab (DUOBODY-CD3xCD20) ELISA for determination of Epcoritamab (DUOBODY-CD3xCD20) in human serum, plasma and cell culture supernatant

KRIBIOLISA™ Epratuzumab (LYMPHOCIDE) ELISA

Reference: KBI1313

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Epratuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Eptinezumab (VYEPTI) ELISA

Reference: KBI1314

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Eptinezumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Erenumab (AIMOVIG) ELISA

Reference: KBI1315

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Erenumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ertumaxomab (REXOMUN) ELISA

Reference: KBI1317

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ertumaxomab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Etaracizumab (ABEGRIN) ELISA

Reference: KBI1318

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Etaracizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Etigilimab ELISA

Reference: KBI1319

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Etigilimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Etrolizumab ELISA

Reference: KBI1321

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Etrolizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Evinacumab ELISA

Reference: KBI1322

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Evinacumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Evolocumab ELISA

Reference: KBI1323

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Evolocumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Faricimab ELISA

Reference: KBI1326

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Faricimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Farletuzumab ELISA

Reference: KBI1327

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Farletuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Fasinumab ELISA

Reference: KBI1328

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Fasinumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Fletikumab ELISA

Reference: KBI1336

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Fletikumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Flotetuzumab ELISA

Reference: KBI1337

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Flotetuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Fremanezumab (AJOVY) ELISA

Reference: KBI1341

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Fremanezumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Fresolimumab ELISA

Reference: KBI1342

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Fresolimumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Fulranumab ELISA

Reference: KBI1345

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Fulranumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Galcanezumab (EMGALITY) ELISA

Reference: KBI1347

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Galcanezumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gancotamab ELISA

Reference: KBI1349

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gancotamab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ganitumab ELISA

Reference: KBI1350

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ganitumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Garadacimab ELISA

Reference: KBI1352

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Garadacimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Garetosmab ELISA

Reference: KBI1353

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Garetosmab in serum and plasma.Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gatipotuzumab ELISA

Reference: KBI1354

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gatipotuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gemtuzumab Ozogamicin (MYLOTARG) ELISA

Reference: KBI1359

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gemtuzumab Ozogamicin in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gevokizumab ELISA

Reference: KBI1360

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gevokizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gimsilumab ELISA

Reference: KBI1362

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gimsilumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Girentuximab (RENCAREX) ELISA

Reference: KBI1363

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Girentuximab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Glenzocimab ELISA

Reference: KBI1365

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Glenzocimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Glofitamab ELISA

Reference: KBI1366

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Glofitamab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gosuranemab ELISA

Reference: KBI1368

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gosuranemab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Gremubamab ELISA

Reference: KBI1369

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Gremubamab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Guselkumab (TREMFYA) ELISA

Reference: KBI1370

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Guselkumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Humax-IL8 ELISA

Reference: KBI1372

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of IL8 in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ianalumab ELISA

Reference: KBI1373

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ianalumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ibalizumab ELISA

Reference: KBI1374

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ibalizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ibritumomab ELISA

Reference: KBI1375

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ibritumomab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ibritumomab Tiuxetan (ZEVALIN) ELISA

Reference: KBI1376

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ibritumomab Tiuxetan in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Idarucizumab (PRAXBIND) ELISA

Reference: KBI1378

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Idarucizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ifabotuzumab ELISA

Reference: KBI1380

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ifabotuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Iladatuzumab ELISA

Reference: KBI1382

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Iladatuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Inclacumab ELISA

Reference: KBI1389

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Inclacumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Inebilizumab (UPLIZNA) ELISA

Reference: KBI1393

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Inebilizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Inolimomab (LEUKOTAC) ELISA

Reference: KBI1395

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Inolimomab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Isatuximab (SARCLISA) ELISA

Reference: KBI1399

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Isatuximab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Iscalimab ELISA

Reference: KBI1400

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Iscalimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Istiratumab ELISA

Reference: KBI1401

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Istiratumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Itolizumab (ALZUMAB) ELISA

Reference: KBI1402

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Itolizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ixekizumab (TALTZ) ELISA

Reference: KBI1404

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ixekizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lacnotuzumab ELISA

Reference: KBI1408

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lacnotuzumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ladiratuzumab Vedotin ELISA

Reference: KBI1411

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ladiratuzumab Vedotin in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lampalizumab ELISA

Reference: KBI1412

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lampalizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lanadelumab (TAKHZYRO) ELISA

Reference: KBI1413

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lanadelumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lebrikizumab ELISA

Reference: KBI1418

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lebrikizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lenzilumab ELISA

Reference: KBI1421

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lenzilumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Leronlimab ELISA

Reference: KBI1423

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Leronlimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Letolizumab ELISA

Reference: KBI1425

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Letolizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Levilimab ELISA

Reference: KBI1426

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Levilimab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Ligelizumab ELISA

Reference: KBI1430

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Ligelizumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lirilumab ELISA

Reference: KBI1435

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lirilumab in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Loncastuximab Tesirine ELISA

Reference: KBI1440

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Loncastuximab Tesirine in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lorvotuzumab Mertansine ELISA

Reference: KBI1441

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lorvotuzumab Mertansine in serum and plasma. Lead Time 3 - 4 weeks.

KRIBIOLISA™ Lulizumab Pegol ELISA

Reference: KBI1445

€0.00 (tax incl.)

Enzyme Immunoassay for the quantitative determination of Lulizumab Pegol in serum and plasma. Lead Time 3 - 4 weeks.

List of products by brand Krishgen

Menu

Settings